You are here: vision-research.eu » News » Newsdetails: Low-dose ranibizumab effective for retinopathy of...

Health

Low-dose ranibizumab effective for retinopathy of prematurity

February 10, 2018

A low dose of ranibizumab (Lucentis, Genentech/Roche) works well as a treatment for retinopathy of prematurity (ROP), researchers say.


Missing some information on vision-research.eu?

* mandatory field